Improving Early Recognition of ILD and the Management of IPF: Idiopathic Pulmonary Fibrosis: Developing Evidence-Based Management Plans

Treatment of ILD can be a challenge for clinicians; poor outcomes and health-related quality of life attest to the significant care gaps and treatment limitations that remain. Advances in the treatment of ILD, and particularly in idiopathic pulmonary fibrosis, hold promise for improved care and patient outcomes. This activity will examine management strategies for IPF.
 
Educational Partner: MCM Education

Medium: Online Presentation

Commerical Support: This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Target Audience

This activity has been designed for pulmonologists, radiologists, pathologists, primary care and other health care providers who encounter patients with ILD.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Recognize risk factors for IPF;
  • Use current evidence-based guidelines for the treatment of IPF to create individualized management strategies for patients with IPF;
  • Describe conditions commonly found comorbidly with IPF and recognize the role of treating these conditions in a comprehensive IPF management plan.
Additional information
ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Interpersonal and Communication Skills
For more information, please contact:
CME Coordinator Contact Name: 
MCM Education
CME Coordinator Contact Phone: 
267-364-0556
Summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
Activity opens: 
08/22/2018
Activity expires: 
08/22/2019
COURSE FACULTY
  Mary E. Strek, MD
  Professor of Medicine
  Director, University of Chicago
  Interstitial Lung Disease Program
  Chair, Pulmonary Fibrosis Foundation
  Clinical Care Network Registry Ancillary Studies Committee
                             Chicago, IL
 
  Kevin R. Flaherty, MD, MS
  Professor of Medicine
  Director, University of Michigan
  Interstitial Lung Disease Program
  Chair, Pulmonary Fibrosis Foundation Clinical Care Network/
  Registry Steering Committee
                            Ann Arbor, MI
 

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Physicians Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and MCM Education. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Other Healthcare Physicians Credit
Nurses and other health care professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the ACCME, please consult your professional licensing board.

Accreditation Period

Activity opens: 
08/22/2018
Activity expires: 
08/22/2019
Registration: To view this activity, you will need to visit the Univadis website.
Click here to view the activity or if you are logged in click on the "Complete Activity" button!
 
Please login or create an account to proceed.